Prof. Reubinoff received his M.D. degree from the Hebrew University - Hadassah Medical School, Jerusalem, Israel, and completed his residency in Obstetrics and Gynecology at the Hadassah Medical Center. He holds a PhD degree in developmental biology from Monash University, Melbourne, Australia. Prof. Reubinoff serves as Chairman of the Department of Obstetrics and Gynecology at Hadassah University Medical Center, Jerusalem and is the director of the Sidney and Judy Swartz Embryonic Stem Cell Research Center of the Goldyne Savad Institute of Gene Therapy at Hadassah. He founded and serves as the Chief Scientific Officer (CSO) of Cell Cure Neurosciences Ltd.

The major focus of Prof. Reubinoff’s research has been human embryonic stem cells (hESCs). Professor Reubinoff has been among the world pioneers in deriving ES cell lines from human embryos.

Prof. Reubinoff's main interests involve the development of the technologies that allow the exploitation of hESCs for regenerative medicine. Towards this goal, he established hESC lines that are suitable for clinical applications, and further derived progeny from these hESC lines for the treatment of neural and retinal degenerative disorders.